1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
86.85%
EBIT growth below 50% of WEED.TO's 411.38%. Michael Burry would suspect deeper competitive or cost structure issues.
86.85%
Operating income growth under 50% of WEED.TO's 411.38%. Michael Burry would be concerned about deeper cost or sales issues.
87.46%
Net income growth under 50% of WEED.TO's 177.72%. Michael Burry would suspect the firm is falling well behind a key competitor.
87.70%
EPS growth at 75-90% of WEED.TO's 101.22%. Bill Ackman would push for improved profitability or share repurchases to catch up.
87.70%
Diluted EPS growth at 75-90% of WEED.TO's 101.41%. Bill Ackman would expect further improvements in net income or share count reduction.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1323.70%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-1323.70%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1020.71%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-1020.71%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-1020.71%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
38.34%
Below 50% of WEED.TO's 14511.20%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
38.34%
Below 50% of WEED.TO's 14511.20%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
38.34%
Below 50% of WEED.TO's 912.40%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-57.28%
Negative equity/share CAGR over 10 years while WEED.TO stands at 45.28%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-57.28%
Negative 5Y equity/share growth while WEED.TO is at 45.28%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-57.28%
Negative 3Y equity/share growth while WEED.TO is at 57.33%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-69.26%
Firm’s AR is declining while WEED.TO shows 28.43%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-32.28%
Negative asset growth while WEED.TO invests at 4.15%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-5.59%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-104.07%
We cut SG&A while WEED.TO invests at 51.17%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.